Status:
UNKNOWN
ICG-NIR Guided Lymph Node Dissection in Gastric Cancer
Lead Sponsor:
Ho Seok Seo
Conditions:
Stomach Neoplasm
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery ...
Eligibility Criteria
Inclusion
- dignosed gastric adenocarcinoma
- tumor: size 4cm or smaller
- depth of invasion: mucosa, submucosa, proper muscle
- candidates of laparoscopic radical gastrectomy
- informed consent
Exclusion
- metachronous malignancy
- number of tumors: 2 or more
- remnant gastric cancer
- indication for endoscopic resection
- history of chemotherapy or radiation therapy
- pregnancy
- allergy to ICG
- metastatic gastric cancer
Key Trial Info
Start Date :
March 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT04056260
Start Date
March 20 2020
End Date
December 31 2020
Last Update
March 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.